1-25454282-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_018202.6(MACO1):c.373G>A(p.Val125Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,604,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
MACO1
NM_018202.6 missense
NM_018202.6 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 9.60
Genes affected
MACO1 (HGNC:25572): (macoilin 1) Predicted to enable actin filament binding activity and microtubule binding activity. Involved in neuronal signal transduction. Located in rough endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.827
BS2
High AC in GnomAd4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACO1 | NM_018202.6 | c.373G>A | p.Val125Met | missense_variant | 4/11 | ENST00000374343.5 | NP_060672.2 | |
MACO1 | NM_001282564.2 | c.373G>A | p.Val125Met | missense_variant | 4/9 | NP_001269493.1 | ||
MACO1 | XM_005245931.3 | c.373G>A | p.Val125Met | missense_variant | 4/10 | XP_005245988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MACO1 | ENST00000374343.5 | c.373G>A | p.Val125Met | missense_variant | 4/11 | 1 | NM_018202.6 | ENSP00000363463.4 | ||
MACO1 | ENST00000399766.7 | c.373G>A | p.Val125Met | missense_variant | 4/9 | 1 | ENSP00000382668.3 | |||
MACO1 | ENST00000470035.1 | n.66G>A | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
MACO1 | ENST00000647928.1 | n.373G>A | non_coding_transcript_exon_variant | 4/11 | ENSP00000497738.1 |
Frequencies
GnomAD3 genomes AF: 0.0000659 AC: 10AN: 151788Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
10
AN:
151788
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245484Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 132888
GnomAD3 exomes
AF:
AC:
8
AN:
245484
Hom.:
AF XY:
AC XY:
5
AN XY:
132888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000124 AC: 180AN: 1452834Hom.: 0 Cov.: 31 AF XY: 0.000107 AC XY: 77AN XY: 722438
GnomAD4 exome
AF:
AC:
180
AN:
1452834
Hom.:
Cov.:
31
AF XY:
AC XY:
77
AN XY:
722438
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000659 AC: 10AN: 151788Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 74082
GnomAD4 genome
AF:
AC:
10
AN:
151788
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
74082
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.373G>A (p.V125M) alteration is located in exon 4 (coding exon 4) of the TMEM57 gene. This alteration results from a G to A substitution at nucleotide position 373, causing the valine (V) at amino acid position 125 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;P
Vest4
MVP
MPC
2.6
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at